Intestinal CYP3A5 genotype and MDR1 expression influence apparent clearance of tacrolimus in adult living-donor liver transplant recipients

被引：0
|
作者：
Fukudo, Masahide
Yoshimura, Atsushi
Yano, Ikuko
Masuda, Satohiro
Uesugi, Miwa
Hosohata, Keiko
Katsura, Toshiya
Takada, Yasutsugu
Uemoto, Shinji
Inui, Ken-ichi
机构：
[1] Kyoto Univ Hosp, Dept Pharm, Kyoto 606, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Transplantat & Immunol, Kyoto, Japan
来源：
THERAPEUTIC DRUG MONITORING | 2007年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
73
引用
收藏
页码：484 / 484
页数：1
相关论文
共 50 条
  • [1] Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients
    Fukudo, Masahide
    Yano, Ikuko
    Yoshimura, Atsushi
    Masuda, Satohiro
    Uesugi, Miwa
    Hosohata, Keiko
    Katsura, Toshiya
    Ogura, Yasuhiro
    Oike, Fumitaka
    Takada, Yasutsugu
    Uemoto, Shinji
    Inui, Ken-ichi
    [J]. PHARMACOGENETICS AND GENOMICS, 2008, 18 (05): : 413 - 423
  • [2] Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients
    Uesugi, Miwa
    Masuda, Satohiro
    Katsura, Toshiya
    Oike, Fumitaka
    Takada, Yasutsugu
    Inui, Ken-ichi
    [J]. PHARMACOGENETICS AND GENOMICS, 2006, 16 (02): : 119 - 127
  • [3] Initial dosage adjustment for oral administration of tacrolimus using the intestinal MDR1 level in living-donor liver transplant recipients
    Masuda, S
    Goto, M
    Okuda, M
    Ogura, Y
    Oike, F
    Kiuchi, T
    Tanaka, K
    Inui, K
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (04) : 1728 - 1729
  • [4] Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients
    Tsuchiya, N
    Satoh, S
    Tada, H
    Li, ZH
    Ohyama, C
    Sato, K
    Suzuki, T
    Habuchi, T
    Kato, T
    [J]. TRANSPLANTATION, 2004, 78 (08) : 1182 - 1187
  • [5] Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation
    Hashida, T
    Masuda, S
    Uemoto, S
    Saito, H
    Tanaka, K
    Inui, K
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (05) : 308 - 316
  • [6] Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients
    Muraki, Yuichi
    Usul, Masanobu
    Isaji, Shuji
    Mizuno, Shugo
    Nakatani, Kaname
    Yamada, Tomomi
    Iwamoto, Takuya
    Uemoto, Shinji
    Nobori, Tsutomu
    Okuda, Masahiro
    [J]. ANNALS OF TRANSPLANTATION, 2011, 16 (04) : 55 - 62
  • [7] A Systematic Review of the Effect of CYP3A5 Genotype on the Apparent Oral Clearance of Tacrolimus in Renal Transplant Recipients
    Barry, Arden
    Levine, Marc
    [J]. THERAPEUTIC DRUG MONITORING, 2010, 32 (06) : 708 - 714
  • [8] MDR1 Haplotypes Conferring an Increased Expression of Intestinal CYP3A4 Rather than MDR1 in Female Living-Donor Liver Transplant Patients
    Keiko Hosohata
    Satohiro Masuda
    Atsushi Yonezawa
    Toshiya Katsura
    Fumitaka Oike
    Yasuhiro Ogura
    Yasutsugu Takada
    Hiroto Egawa
    Shinji Uemoto
    Ken-ichi Inui
    [J]. Pharmaceutical Research, 2009, 26 : 1590 - 1595
  • [9] Impact of Donor and Recipient CYP3A5*3 Genotype on Tacrolimus Population Pharmacokinetics in Chinese Adult Liver Transplant Recipients
    Shao, Jia
    Wang, Chenyu
    Fu, Peng
    Chen, Fan
    Zhang, Yi
    Wei, Jinxia
    [J]. ANNALS OF PHARMACOTHERAPY, 2020, 54 (07) : 652 - 661
  • [10] MDR1 Haplotypes Conferring an Increased Expression of Intestinal CYP3A4 Rather than MDR1 in Female Living-Donor Liver Transplant Patients
    Hosohata, Keiko
    Masuda, Satohiro
    Yonezawa, Atsushi
    Katsura, Toshiya
    Oike, Fumitaka
    Ogura, Yasuhiro
    Takada, Yasutsugu
    Egawa, Hiroto
    Uemoto, Shinji
    Inui, Ken-ichi
    [J]. PHARMACEUTICAL RESEARCH, 2009, 26 (07) : 1590 - 1595
12345